Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Dectin-1 Receptor Signaling Pathway Mediates the Remyelination Effect of Lentinan through Suppression of Neuroinflammation and Conversion of Microglia. | J Immunol Res | 2022 | 36619719 | PubTator, text mining | PubMed |
| Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer. | Ann Transl Med | 2022 | 36618780 | PubTator, text mining | PubMed |
| MiR-302a Regenerates Human Corneal Endothelial Cells against IFN-γ-Induced Cell Death. | Cells | 2022 | 36611829 | PubTator, text mining | PubMed |
| Genetic association between the PTPN22, IRF5 and TYK2 gene variants and susceptibility to juvenile idiopathic arthritis. | Exp Ther Med | 2022 | 36605568 | PubTator, text mining | PubMed |
| Explaining the polarized macrophage pool during murine allergic lung inflammation. | Front Immunol | 2022 | 36605195 | PubTator, text mining | PubMed |
| Biomaterials delivery strategies to repair spinal cord injury by modulating macrophage phenotypes. | J Tissue Eng | 2022 | 36600997 | PubTator, text mining | PubMed |
| Black patients with cutaneous lupus are associated with positive family history of cutaneous lupus and systemic lupus. | Lupus Sci Med | 2022 | 36600582 | PubTator, text mining | PubMed |
| Interferon signature in systemic autoimmune diseases: what does it mean? | RMD Open | 2022 | 36597991 | PubTator, text mining | PubMed |
| Aberrant B-Cell Activation in Systemic Lupus Erythematosus. | Kidney Dis (Basel) | 2022 | 36590680 | PubTator, text mining | PubMed |
| High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma. | Diagn Pathol | 2022 | 36585741 | PubTator, text mining | PubMed |
| SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer. | BMC Cancer | 2022 | 36585688 | PubTator, text mining | PubMed |
| Integrated molecular analyses of an interferon-γ based subtype with regard to outcome, immune characteristics, and immunotherapy in bladder cancer and experimental verification. | Heliyon | 2022 | 36582677 | PubTator, text mining | PubMed |
| Anticancer activity of glycoalkaloids from Solanum plants: A review. | Front Pharmacol | 2022 | 36569285 | PubTator, text mining | PubMed |
| Inflammatory Bowel Diseases Are Associated with Polymyositis and Dermatomyositis-A Retrospective Cohort Analysis. | Medicina (Kaunas) | 2022 | 36556929 | PubTator, text mining | PubMed |
| Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies. | Int J Mol Sci | 2022 | 36555640 | PubTator, text mining | PubMed |
| Temporal Analysis Reveals the Transient Differential Expression of Transcription Factors That Underlie the Trans-Differentiation of Human Monocytes to Macrophages. | Int J Mol Sci | 2022 | 36555471 | PubTator, text mining | PubMed |
| PVR-A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma. | Diagnostics (Basel) | 2022 | 36552960 | PubTator, text mining | PubMed |
| Expression of Steroid Receptor RNA Activator 1 (SRA1) in the Adipose Tissue Is Associated with TLRs and IRFs in Diabesity. | Cells | 2022 | 36552771 | PubTator, text mining | PubMed |
| The Role of Hydrogen Sulfide in Plaque Stability. | Antioxidants (Basel) | 2022 | 36552564 | PubTator, text mining | PubMed |
| Exosomes in Cerebral Ischemia-Reperfusion Injury: Current Perspectives and Future Challenges. | Brain Sci | 2022 | 36552117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=34